Device Trial Radar · NCT01478061
Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device
Last checked: Nov 20, 2026Latest source record: Jul 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Cardica, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Study plan is a post-market prospective, multi-center, open-label registry. The vein graft failure rates for the currently commercialized C-Port devices will be compared to an a priori rate taken from the peer-reviewed literature.
Conditions
- Heart Disease
Interventions
Anastomosis (C-Port® )Device
creation of anastomoses in blood vessels and grafts, including use in coronary artery bypass grafting procedures
Primary outcomes
What the sponsor says the trial is designed to measure.
- Graft patency rates for coronary revascularization when in general use in the United States compared to hand-sewn anastomoses.Time frame: 12 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas
Little Rock, Arkansas
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.